Prioritising cardiovascular disease risk assessment to high risk individuals based on primary care records

Author:

Chung RyanORCID,Xu ZheORCID,Arnold Matthew,Stevens David,Keogh Ruth,Barrett Jessica,Harrison Hannah,Pennells Lisa,Kim Lois G.ORCID,DiAngelantonio Emanuele,Paige EllieORCID,Usher-Smith Juliet A.ORCID,Wood Angela M.

Abstract

Objective To provide quantitative evidence for systematically prioritising individuals for full formal cardiovascular disease (CVD) risk assessment using primary care records with a novel tool (eHEART) with age- and sex- specific risk thresholds. Methods and analysis eHEART was derived using landmark Cox models for incident CVD with repeated measures of conventional CVD risk predictors in 1,642,498 individuals from the Clinical Practice Research Datalink. Using 119,137 individuals from UK Biobank, we modelled the implications of initiating guideline-recommended statin therapy using eHEART with age- and sex-specific prioritisation thresholds corresponding to 5% false negative rates to prioritise adults aged 40–69 years in a population in England for invitation to a formal CVD risk assessment. Results Formal CVD risk assessment on all adults would identify 76% and 49% of future CVD events amongst men and women respectively, and 93 (95% CI: 90, 95) men and 279 (95% CI: 259, 297) women would need to be screened (NNS) to prevent one CVD event. In contrast, if eHEART was first used to prioritise individuals for formal CVD risk assessment, we would identify 73% and 47% of future events amongst men and women respectively, and a NNS of 75 (95% CI: 72, 77) men and 162 (95% CI: 150, 172) women. Replacing the age- and sex-specific prioritisation thresholds with a 10% threshold identify around 10% less events. Conclusions The use of prioritisation tools with age- and sex-specific thresholds could lead to more efficient CVD assessment programmes with only small reductions in effectiveness at preventing new CVD events.

Funder

British Heart Foundation

BHF Cambridge Centre of Research Excellence

NIHR Cambridge Biomedical Research Centre

Medical Research Council

Chinese Scholarship Council

NIHR BTRU in Donor Health and Genomics

NIHR BTRU in Donor Health and Behaviour

NIHR Advanced Fellowship

Innovative Medicines Initiative-2 Joint Undertaking

BHF-Turing Cardiovascular Data Science Award

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. WHO/Europe | Cardiovascular diseases ‐ Data and statistics [Internet]. [cited 2022 Apr 1]. Available from: https://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/data-and-statistics

2. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute CVD risk 2012 [Internet]. 2012 [cited 2021 Nov 23]. Available from: https://informme.org.au/en/Guidelines/Guidelines-for-the-assessment-and-management-of-absolute-CVD-risk

3. ESC Guidelines on cardiovascular disease prevention in clinical practice;FLJ Visseren;Eur Heart J,2021

4. New Zealand Ministry of Health;Cardiovascular Disease Risk Assessment and Management for Primary Care,2018

5. ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;DK Arnett;Circulation,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3